Download PDF
Deutsche Zeitschrift für Onkologie 2021; 53(02): 52-58
DOI: 10.1055/a-1471-7947
Forschung

Informationsbedarf Komplementärmedizin in der Onkologie

Information Requirements for Complementary Medicine in Oncology
Petra Klose
1   Evang. Kliniken Essen-Mitte, Klinik für Naturheilkunde & Integrative Medizin
,
Petra Voiß
2   Evang. Kliniken Essen-Mitte, Klinik für Senologie / Integrative Onkologie
,
Sherko Kümmel
3   Evang. Kliniken Essen-Mitte, Breast Unit
,
Gustav Dobos
1   Evang. Kliniken Essen-Mitte, Klinik für Naturheilkunde & Integrative Medizin
,
Claudia M. Witt
4   Institut für komplementäre und integrative Medizin, Universitätsspital Zürich und Universität Zürich, Zürich, Schweiz
,
Silke Lange
2   Evang. Kliniken Essen-Mitte, Klinik für Senologie / Integrative Onkologie
› Author Affiliations
› Further Information
    Permissions and Reprints

ZUSAMMENFASSUNG

Onkologisch tätige Ärzte und Ärztinnen vermeiden es häufig, mit ihren Patienten das Thema komplementäre Therapien anzuschneiden, da sie sich selbst nicht ausreichend informiert fühlen. Das kann sich ungünstig auf die langfristige Interaktion zwischen Arzt und onkologisch Erkranktem auswirken, der – so besagen es die Zahlen – höchstwahrscheinlich genau über diese Themen kompetent informiert werden möchte. Um diesem Bedürfnis nachzukommen, stellen sich dem Mediziner also drei Fragen: Woher bekomme ich verlässliche und fundierte Informationen, wie kommuniziere ich mein Wissen und gebe Empfehlungen und was möchte ich möglicherweise selbst an komplementärmedizinischen Therapien anbieten? In diesem Artikel werden die wichtigsten deutschsprachigen Informationsplattformen, Weiterbildungsprogramme für Onkologen und Ausbildungskurse diverser komplementärmedizinischer Therapien vorgestellt.

Abstract

Oncology physicians often avoid addressing the area of complementary treatment options with their patients because they themselves do not feel sufficiently informed. This can have an unfavorable effect on the long-term interaction between the physician and the oncological patient, who - according to the figures - most likely wants to be informed competently about precisely these topics. To meet this need, therefore, the physician faces three questions: where do I get reliable and sound information, how do I communicate my knowledge and make recommendations, and what complementary medicine therapies do I possibly want to offer myself? This article presents the most important German-language information platforms, continuing education programs for oncologists, and training courses of various complementary medicine therapies.

Schlüsselwörter

Krebs - Integrative Onkologie - Informationsbedarf Komplementärmedizin - Weiterbildung Komplementärmedizin

Key words

Cancer - integrative oncology - information requirements for complementary medicine - advanced training in complementary medicine


Publication History

Article published online:
24 June 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Zentrum für Krebsregisterdaten des RKI Im Internet https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Krebs_gesamt/krebs_gesamt_node.html Zugegriffen: 08.03.2021
    PubMed
  • 2 Denieffe S, Gooney M. A meta-synthesis of women's symptoms experience and breast cancer. Eur J Cancer Care (Engl) 2011; 20: 424-435
    CrossrefPubMedGoogle Scholar
  • 3 Haidinger R, Bauerfeind I. Long-term side effects of adjuvant therapy in primary breast cancer patients: Results of a web-based survey. Breast Care (Basel) 2019; 14: 111-116
    CrossrefPubMedGoogle Scholar
  • 4 Fremd C, Hack CC, Schneeweiss A. et al. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network. Arch Gynecol Obstet 2017; 295: 1239-1245
    CrossrefPubMedGoogle Scholar
  • 5 Keene MR, Heslop IM, Sabesan SS. et al. Complementary and alternative medicine use in cancer: A systematic review. Complement Ther Clin Pract 2019; 35: 33-47
    CrossrefPubMedGoogle Scholar
  • 6 Grimm D, Mathes S, Woelber L. et al. Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany. Arch Gynecol Obstet. 2020: epub DOI: 10.1007/s00404-020-05880-0
    CrossrefPubMedGoogle Scholar
  • 7 Munstedt K, Vogt T, Rabanus ME. et al. Wishes and beliefs of cancer patients regarding counseling on integrative medicine. Breast Care (Basel) 2014; 9: 416-420
    CrossrefPubMedGoogle Scholar
  • 8 Corina G, Christine H, Klein G. Oncologists’ experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis. Support Care Cancer 2016; 24: 3857-3862
    CrossrefPubMedGoogle Scholar
  • 9 Paepke D, Wiedeck C, Hapfelmeier A. et al. Prevalence and predictors for nonuse of complementary medicine among breast and gynecological cancer patients. Breast Care (Basel) 2020; 15: 380-385
    CrossrefPubMedGoogle Scholar
  • 10 Grimm D, Voiss P, Paepke D. et al. Gynecologists’ attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany. Arch Gynecol Obstet 2021; 303: 967-980 DOI: 10.1007/s00404-020-05869-9.
    CrossrefPubMedGoogle Scholar
  • 11 Koenig CJ, Ho EY, Trupin L. et al. An exploratory typology of provider responses that encourage and discourage conversation about complementary and integrative medicine during routine oncology visits. Patient Educ Couns 2015; 98: 857-863
    CrossrefPubMedGoogle Scholar
  • 12 Samuels N, Ben-Arye E, Maimon Y. et al. Unmonitored use of herbal medicine by patients with breast cancer: reframing expectations. J Cancer Res Clin Oncol 2017; 143: 2267-2273
    CrossrefPubMedGoogle Scholar
  • 13 Klein E, Beckmann MW, Bader W. et al. Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey. Arch Gynecol Obstet 2017; 296: 295-301
    CrossrefPubMedGoogle Scholar
  • 14 Witt CM, Helmer SM, Schofield P. et al. Training oncology physicians to advise their patients on complementary and integrative medicine: An implementation study for a manual-guided consultation. Cancer 2020; 126: 3031-3041
    CrossrefPubMedGoogle Scholar
  • 15 Akpunar D, Bebis H, Yavan T. Use of complementary and alternative medicine in patients with gynecologic cancer: a systematic review. Asian Pac J Cancer Prev 2015; 16: 7847-7852
    CrossrefPubMedGoogle Scholar
  • 16 Drozdoff L, Klein E, Kiechle M. et al. Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy. BMC Complement Altern Med 2018; 18: 259
    CrossrefPubMedGoogle Scholar
  • 17 Epstein RM, Street RL. The values and value of patient-centered care. Ann Fam Med 2011; 9: 100-103
    CrossrefPubMedGoogle Scholar
  • 18 Epstein RM. SR Jr. Patient-centered communication in cancer care: promoting healing and reducing suffering: National Cancer Institute. NIH Publication No. 07-6225. Bethesda, MD. 2007
    CrossrefGoogle Scholar
  • 19 Pincus HA, Patel SR. Barriers to the delivery of psychosocial care for cancer patients: bridging mind and body. J Clin Oncol 2009; 27: 661-662
    CrossrefPubMedGoogle Scholar
  • 20 Frenkel M, Ben-Arye E, Cohen L. Communication in cancer care: discussing complementary and alternative medicine. Integr Cancer Ther 2010; 9: 177-185
    CrossrefPubMedGoogle Scholar
  • 21 Street RL, Slee C, Kalauokalani DK. et al. Improving physician-patient communication about cancer pain with a tailored education-coaching intervention. Patient Educ Couns 2010; 80: 42-47
    CrossrefPubMedGoogle Scholar
  • 22 Boywitt D. Methodische Grundlagen V1.1. IQTIG-Institut für Qualitätssicherung und Transparenz im Gesundheitswesen. Berlin. 2019
    PubMedGoogle Scholar
  • 23 Cochrane Deutschland. Evidenzbasierte Medizin. Glossar Im Internet https://www.cochrane.de/de/cochrane-glossar#e
    PubMed
  • 24 Witt CM, Balneaves LG, Carlson LE. et al. Education competencies for integrative oncology – results of a systematic review and an international and interprofessional consensus procedure. J Cancer Educ. 2020: epub DOI: 10.1007/s13187-020-01829-8
    CrossrefPubMedGoogle Scholar
  • 25 Witt CM, Bartsch HH, Güthlin C. et al. Kompetenznetz Komplementärmedizin in der Onkologie (KOKON) Ein wissenschaftlicher Beitrag zur Verbesserung der Versorgung. FORUM 2017; 32: 416-423
    CrossrefPubMedGoogle Scholar
  • 26 Klein GE, Guethlin C. Information and training needs regarding complementary and alternative medicine: A cross-sectional study of cancer care providers in Germany. Integr Cancer Ther 2018; 17: 380-387
    CrossrefPubMedGoogle Scholar
  • 27 Witt CM, Müller T. Komplementärmedizin in der gynäkologisch-onkologischen Sprechstunde: Wie mache ich mich fit dafür?. Gynäkologe 2021; 54: 32-37
    CrossrefPubMedGoogle Scholar
  • 28 AlOmeir O, Patel N, Donyai P. Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory. Support Care Cancer 2020; 28: 5075-5084
    CrossrefPubMedGoogle Scholar
  • 29 Cardoso F, Paluch-Shimon S, Senkus E. et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol 2020; 31: 1623-1649
    CrossrefPubMedGoogle Scholar
  • 30 Fabi A, Bhargava R, Fatigoni S. Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. Ann Oncol 2020; 31: 713-723
    CrossrefPubMedGoogle Scholar
  • 31 Jordan B, Margulies A, Cardoso F. et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol 2020; 31: 1306-1319
    CrossrefPubMedGoogle Scholar
  • 32 Greenlee H, DuPont-Reyes MJ, Balneaves LG. et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin 2017; 67: 194-232
    CrossrefPubMedGoogle Scholar